These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32622524)

  • 1. DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients.
    Said SM; Leung N; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera LH; Sethi S; Zhang P; Nasr SH
    Kidney Int; 2020 Aug; 98(2):498-504. PubMed ID: 32622524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction.
    Kudose S; Canetta P; Andeen NK; Stokes MB; Batal I; Markowitz GS; D'Agati VD; Santoriello D
    Kidney Int Rep; 2021 Apr; 6(4):936-945. PubMed ID: 33912743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges.
    Da Y; Goh GH; Lau T; Chng WJ; Soekojo CY
    Front Oncol; 2022; 12():880923. PubMed ID: 35692803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunofluorescence staining for immunoglobulin heavy chain/light chain on kidney biopsies is a valuable ancillary technique for the diagnosis of monoclonal gammopathy-associated kidney diseases.
    Nasr SH; Fidler ME; Said SM; Koepplin JW; Altamirano-Alonso JM; Leung N
    Kidney Int; 2021 Jul; 100(1):155-170. PubMed ID: 33774084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.
    Liang S; Chen D; Liang D; Xu F; Zhang M; Yang F; Zhu X; Li P; Zeng C
    J Nephrol; 2021 Jun; 34(3):883-892. PubMed ID: 32557205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases.
    Said SM; Rocha AB; Royal V; Valeri AM; Larsen CP; Theis JD; Vrana JA; McPhail ED; Bandi L; Safabakhsh S; Barnes C; Cornell LD; Fidler ME; Alexander MP; Leung N; Nasr SH
    Am J Kidney Dis; 2021 Mar; 77(3):454-458. PubMed ID: 32711071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA J homolog subfamily B member 9 and other advances in fibrillary glomerulonephritis.
    Andeen NK; Avasare RS
    Curr Opin Nephrol Hypertens; 2021 May; 30(3):294-302. PubMed ID: 33767057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA-dominant glomerulonephritis with DNAJB9-negative fibrillar polytypic immunoglobulin deposits in the subepithelium.
    Muto R; Maeda K; Fukui S; Saito S; Kato N; Kosugi T; Shimizu A; Maruyama S
    CEN Case Rep; 2023 Aug; 12(3):323-328. PubMed ID: 36576710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series.
    El Ters M; Bobart SA; Cornell LD; Leung N; Bentall A; Sethi S; Fidler M; Grande J; Hernandez LH; Cosio FG; Zand L; Amer H; Fervenza FC; Nasr SH; Alexander MP
    Am J Kidney Dis; 2020 Oct; 76(4):500-510. PubMed ID: 32414663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrillary Glomerulonephritis, DNAJB9, and the Unfolded Protein Response.
    Andeen NK; Kung VL; Robertson J; Gurley SB; Avasare RS; Sitaraman S
    Glomerular Dis; 2022; 2(4):164-175. PubMed ID: 36817290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN.
    Dasari S; Alexander MP; Vrana JA; Theis JD; Mills JR; Negron V; Sethi S; Dispenzieri A; Highsmith WE; Nasr SH; Kurtin PJ
    J Am Soc Nephrol; 2018 Jan; 29(1):51-56. PubMed ID: 29097623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.
    Rosenstock JL; Markowitz GS; Valeri AM; Sacchi G; Appel GB; D'Agati VD
    Kidney Int; 2003 Apr; 63(4):1450-61. PubMed ID: 12631361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heavy Chain Fibrillary Glomerulonephritis: A Case Report.
    Nasr SH; Sirac C; Bridoux F; Javaugue V; Bender S; Rinsant A; Kaaki S; Pinault E; Dasari S; Alexander MP; Said SM; Hogan JJ; Dispenzieri A; Touchard G; McPhail ED; Leung N
    Am J Kidney Dis; 2019 Aug; 74(2):276-280. PubMed ID: 30955945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillary glomerulonephritis or complement 3 glomerulopathy: a rare case of diffuse necrotising crescentic glomerulonephritis with C3-dominant glomerular deposition and positive DNAJB9.
    Baker LW; Khan M; Cortese C; Aslam N
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33602773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9).
    Klomjit N; Alexander MP; Zand L
    Kidney360; 2020 Sep; 1(9):1002-1013. PubMed ID: 35369552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients.
    Nasr SH; Dasari S; Lieske JC; Benson LM; Vanderboom PM; Holtz-Heppelmann CJ; Giesen CD; Snyder MR; Erickson SB; Fervenza FC; Leung N; Kurtin PJ; Alexander MP
    Kidney Int; 2019 May; 95(5):1269-1272. PubMed ID: 31010480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrillary Glomerulonephritis: Clinicopathologic Features and Atypical Cases from a Multi-Institutional Cohort.
    Andeen NK; Troxell ML; Riazy M; Avasare RS; Lapasia J; Jefferson JA; Akilesh S; Najafian B; Nicosia RF; Alpers CE; Smith KD
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1741-1750. PubMed ID: 31685544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous occurrence of fibrillary glomerulonephritis and renal lesions in nonmalignant monoclonal IgM gammopathy.
    Wu CK; Leu JG; Yang AH; Tarng DC; Tung HY; Chiang SS
    BMC Nephrol; 2016 Feb; 17():17. PubMed ID: 26892336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
    Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
    Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM monoclonal gammopathy with heavy-and-light-chain amyloidosis resembling fibrillary glomerulonephritis determined by tandem mass spectrometry: a case report.
    Adachi M; Kitamura M; Muta K; Maekawa A; Uramatsu T; Tadokoro M; Funakoshi S; Hisano S; Kuwahara N; Shimizu A; Mukae H; Nishino T
    BMC Nephrol; 2020 May; 21(1):195. PubMed ID: 32448180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.